Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	DXCMDexcom	GEHCGE HealthCare	RMDResMed
Snapshot
Price	$69.07	$60.64	$188.45
Market cap	$27.96B	$28.02B	$27.36B
Valuation
P/E	30.3x	15x	18x
Forward P/E	21.7x	17.1x	15.5x
Growth
Revenue growth	16.1%	6.0%	10.3%
EPS growth	77.5%	-12.3%	16.5%
Profitability
Net margin	19.3%	9.1%	27.4%
ROE	33.8%	18.8%	24.4%
Balance sheet & cash
Debt / equity	0.47x	0.97x	0.11x
Free cash flow yield	1.8%	7.7%	3.8%
Dividend yield	—	0.2%	1.2%
Verdict
Investment rating	Favorable· 70	Neutral· 51	Strong· 75

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	DXCMtoday $69	GEHCtoday $61	RMDtoday $188
2027	$91.92 – $134.82+95% CAGR	$46.39 – $68.04+12% CAGR	$164.62 – $241.44+28% CAGR
2028	$163.12 – $239.24+86% CAGR	$47.32 – $69.40+7% CAGR	$191.73 – $281.20+22% CAGR
2029	$289.45 – $424.53+83% CAGR	$48.26 – $70.79+5% CAGR	$223.31 – $327.51+20% CAGR
2030	$513.64 – $753.33+82% CAGR	$49.23 – $72.20+4% CAGR	$260.08 – $381.46+19% CAGR
2031	$911.45 – $1,336.79+81% CAGR	$50.21 – $73.65+4% CAGR	$302.92 – $444.28+19% CAGR
5-yr CAGR	67.5% – 80.9%	-3.7% – 4.0%	10.0% – 18.7%